Marijuana Rx Corporation
(888)453-3339

Fibromyalgia Marijuana Reference

Swedish Study Looks at Inflammatory Factors Related to Fibromyalgia Pain

Fibromyalgia Marijuana Reference

 

References

  1. 1.Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160–172.F. WolfeHA SmytheMB YunusRM BennettC. Bombardier1990The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee.Arthritis Rheum33160172
  2. 2.Abeles AM, Pillinger MH, Solitar BM, Abeles M (2007) Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 146: 726–734.AM AbelesMH PillingerBM SolitarM. Abeles2007Narrative review: the pathophysiology of fibromyalgia.Ann Intern Med146726734
  3. 3.Martinez-Lavin M (2007) Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res Ther 9: 216.M. Martinez-Lavin2007Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia.Arthritis Res Ther9216
  4. 4.Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR (2007) Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin 23: 17–24.M. IskedjianB. BerezaA. GordonC. PiwkoTR Einarson2007Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.Curr Med Res Opin231724
  5. 5.Pacher P, Bátkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58: 389–462.P. PacherS. BátkaiG. Kunos2006The endocannabinoid system as an emerging target of pharmacotherapy.Pharmacol Rev58389462
  6. 6.Schley M, Legler A, Skopp G, Schmelz M, Konrad C, et al. (2006) Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr Med Res Opin 22: 1269–1276.M. SchleyA. LeglerG. SkoppM. SchmelzC. Konrad2006Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.Curr Med Res Opin2212691276
  7. 7.Skrabek RQ, Galimova L, Ethansand Daryl K (2008) Nabilone for the Treatment of Pain in Fibromyalgia. J Pain 9: 164–73.RQ SkrabekL. GalimovaK. Ethansand Daryl2008Nabilone for the Treatment of Pain in Fibromyalgia.J Pain916473
  8. 8.Ware MA, Fitzcharles MA, Joseph L, Shir Y (2010) The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 110: 604–610.MA WareMA FitzcharlesL. JosephY. Shir2010The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.Anesth Analg110604610
  9. 9.Russo EB (2008) Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 29: 192–200.EB Russo2008Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Neuro Endocrinol Lett29192200
  10. 10.Alonso J, Prieto L, Antó JM (1995) La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 104: 771–776.J. AlonsoL. PrietoJM Antó1995La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos.Med Clin (Barc)104771776
  11. 11.Rivera J, Gonzalez T (2004) The Fibromyalgia Impact Questionnaire: A Validated Spanish version to asses the health status in women with fibromyalgia. Clin Exp Rheumatol 22: 554–560.J. RiveraT. Gonzalez2004The Fibromyalgia Impact Questionnaire: A Validated Spanish version to asses the health status in women with fibromyalgia.Clin Exp Rheumatol22554560
  12. 12.Royuela Rico A, Macías Fernández JA (1997) Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburg. Vigilia-Sueño 9: 81–94.A. Royuela RicoJA Macías Fernández1997Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburg.Vigilia-Sueño98194
  13. 13.Lynch ME, Young J, Clark AJ (2006) A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations. J Pain Symptom Manage 32: 497–501.ME LynchJ. YoungAJ Clark2006A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations.J Pain Symptom Manage32497501
  14. 14.Blackburn-Munro G (2004) Hypothalamo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression. Curr Pain Headache Rep 2004; 8: 116–24.G. Blackburn-Munro2004Hypothalamo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression.Curr Pain Headache Rep2004; 811624
  15. 15.Buskila D (2009) Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther 11: 242.D. Buskila2009Developments in the scientific and clinical understanding of fibromyalgia.Arthritis Res Ther11242
  16. 16.Dadabhoy D, Clauw DJ (2006) Therapy insight: fibromyalgia a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2: 364–372.D. DadabhoyDJ Clauw2006Therapy insight: fibromyalgia a different type of pain needing a different type of treatment.Nat Clin Pract Rheumatol2364372
  17. 17.Carrier EJ, Patel S, Hillard CJ (2005) Endocannabinoids in neuroimmunology and stress. Curr Drug Targets CNS Neurol Disord 4: 657–665.EJ CarrierS. PatelCJ Hillard2005Endocannabinoids in neuroimmunology and stress.Curr Drug Targets CNS Neurol Disord4657665
  18. 18.Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161–202.AC HowlettF. BarthTI BonnerG. CabralP. Casellas2002International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.Pharmacol Rev54161202

EQUAL MEDICINE ORGANIZATION - Marijuana ALS Amyotrophic Lateral Sclerosis Treatment cures medical marijuana thc cannabis cbd